Vikas Bhushan

786 total citations
30 papers, 568 citations indexed

About

Vikas Bhushan is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Vikas Bhushan has authored 30 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 8 papers in Oncology and 6 papers in Genetics. Recurrent topics in Vikas Bhushan's work include Acute Myeloid Leukemia Research (5 papers), CAR-T cell therapy research (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). Vikas Bhushan is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), CAR-T cell therapy research (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). Vikas Bhushan collaborates with scholars based in United States, India and Ireland. Vikas Bhushan's co-authors include Thomas H. Jukes, Steven H. Kroft, Monte S. Willis, M. L. Miller, Sara A. Monaghan, Robert W. McKenna, Mary J. Malloy, Thomas M. Amidon, Krishnankutty Sudhir and Thomas A. Ports and has published in prestigious journals such as JAMA, Circulation and Blood.

In The Last Decade

Vikas Bhushan

25 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vikas Bhushan United States 8 143 142 138 112 91 30 568
Emmanuel Bissé Germany 16 64 0.4× 105 0.7× 163 1.2× 109 1.0× 37 0.4× 30 669
Carmelo Iacobello Italy 14 82 0.6× 170 1.2× 192 1.4× 102 0.9× 26 0.3× 35 610
T. C. Iancu Israel 14 140 1.0× 159 1.1× 110 0.8× 75 0.7× 33 0.4× 34 516
Olga Navolotskaia United States 11 45 0.3× 136 1.0× 93 0.7× 65 0.6× 66 0.7× 16 560
Shu‐Fen Wu Taiwan 14 51 0.4× 69 0.5× 201 1.5× 146 1.3× 89 1.0× 24 568
Olivier Thibaudeau France 10 154 1.1× 230 1.6× 120 0.9× 66 0.6× 148 1.6× 15 667
Rakesh R. Misra United States 12 124 0.9× 55 0.4× 287 2.1× 304 2.7× 77 0.8× 18 1.0k
M Gacko Poland 18 29 0.2× 55 0.4× 182 1.3× 237 2.1× 233 2.6× 77 831
Helena Truszczynska United States 5 44 0.3× 37 0.3× 172 1.2× 174 1.6× 183 2.0× 5 729
Joseph Kurantsin‐Mills United States 16 71 0.5× 239 1.7× 122 0.9× 28 0.3× 75 0.8× 38 675

Countries citing papers authored by Vikas Bhushan

Since Specialization
Citations

This map shows the geographic impact of Vikas Bhushan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikas Bhushan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikas Bhushan more than expected).

Fields of papers citing papers by Vikas Bhushan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikas Bhushan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikas Bhushan. The network helps show where Vikas Bhushan may publish in the future.

Co-authorship network of co-authors of Vikas Bhushan

This figure shows the co-authorship network connecting the top 25 collaborators of Vikas Bhushan. A scholar is included among the top collaborators of Vikas Bhushan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikas Bhushan. Vikas Bhushan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harris, Samar, et al.. (2025). ALL-1405: Blinatumomab-Induced Acute Pancreatitis: A Case Report. Clinical Lymphoma Myeloma & Leukemia. 25. S387–S388.
2.
Battiwalla, Minoo, Michael Tees, Ian W. Flinn, et al.. (2024). Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy network. Blood Advances. 9(2). 429–435. 4 indexed citations
3.
Battiwalla, Minoo, José C. Cruz, William B. Donnellan, et al.. (2024). Determinants of Outcomes for Acute Myeloid Leukemia Patients Treated in a Community-Based Specialized Versus Non-Specialized Hospital Setting. PubMed. 6(4). 43–52. 1 indexed citations
4.
Gregory, Tara, Betsy Blunk, Casey Martin, et al.. (2024). Carvykti (cilta-cel) Real World Outcomes across the Sarah Cannon Transplant Cell Therapy Network. Transplantation and Cellular Therapy. 30(2). S385–S386. 1 indexed citations
5.
Battiwalla, Minoo, Michael Tees, Ian W. Flinn, et al.. (2023). Access Barriers for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non-Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network. Transplantation and Cellular Therapy. 29(2). S55–S55. 2 indexed citations
6.
Battiwalla, Minoo, Michael Tees, Ian W. Flinn, et al.. (2023). Outcomes for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network. Transplantation and Cellular Therapy. 29(2). S211–S211.
7.
Bhushan, Vikas, et al.. (2021). Defect Detection Based on Segmentation of Thermographic Images of Frequency Modulated Thermal Wave Imaging. International Journal of Engineering and Advanced Technology. 10(3). 210–216. 1 indexed citations
8.
Koduru, Prasad, Giovanni A. Botten, Jian Xu, et al.. (2020). Mixed Phenotype Acute Leukemia, B/Myeloid (Bilineal and Biphenotypic), With t(2;22)(q35;q12);EWSR1-FEV. Journal of Pediatric Hematology/Oncology. 43(3). e388–e394. 7 indexed citations
9.
Ramakrishnan, Aravind, Paul Shaughnessy, Carlos Bachier, et al.. (2018). Autologous Stem Cell Transplant in Patients with Primary Central Nervous System Lymphoma: A Multicenter Analysis From the Sarah Cannon Blood Cancer Network. Biology of Blood and Marrow Transplantation. 24(3). S259–S260. 1 indexed citations
10.
Le, Tao, et al.. (2007). First aid for the Match : insider advice from students and residency directors. McGraw-Hill eBooks.
11.
Sokol, Lubomir, Larry D. Cripe, Hagop M. Kantarjian, et al.. (2006). Phase I/II, Randomized, MultiCenter, Dose-Ascension Study of the p38MAPK Inhibitor Scio-469 in Patients with Myelodysplastic Syndrome (MDS).. Blood. 108(11). 2657–2657. 2 indexed citations
12.
Butcher, Brad W., Kathleen Wilson, Steven H. Kroft, Robert H. Collins, & Vikas Bhushan. (2005). Acute leukemia with B-lymphoid and myeloid differentiation associated with an inv(5)(q13q33) in an adult patient. Cancer Genetics and Cytogenetics. 157(1). 62–66. 6 indexed citations
13.
Willis, Monte S., Sara A. Monaghan, M. L. Miller, et al.. (2005). Zinc-Induced Copper Deficiency. American Journal of Clinical Pathology. 123(1). 125–131. 186 indexed citations
14.
Le, Tao, Vikas Bhushan, & Chirag Amin. (2003). First aid for the wards : insider advice for the clinical years. McGraw-Hill eBooks. 2 indexed citations
15.
Bhushan, Vikas. (2003). Chronic Graft-vs-Host Disease. JAMA. 290(19). 2599–2599. 55 indexed citations
16.
Taira, Ricky K., David B. Johnson, Vikas Bhushan, et al.. (1996). A concept-based retrieval system for thoracic radiology. Journal of Digital Imaging. 9(1). 25–36. 6 indexed citations
17.
Ho, Bruce K. T., et al.. (1995). <title>Image navigation for PACS workstations</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 2435. 43–49. 2 indexed citations
18.
Chandy, Mammen, et al.. (1994). Treatment of childhood acute lymphoblastic leukaemia with the BFM regimen.. PubMed. 31(2). 78–85. 3 indexed citations
19.
Chandy, Mammen, et al.. (1994). Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen.. PubMed. 31(1). 1–7. 2 indexed citations
20.
Jukes, Thomas H. & Vikas Bhushan. (1986). Silent nucleotide substitutions and G+C content of some mitochondrial and bacterial genes. Journal of Molecular Evolution. 24(1-2). 39–44. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026